{"count":9,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/cbcc6532-409d-4dfe-9ca9-5fbba9b213df/","filing_uuid":"cbcc6532-409d-4dfe-9ca9-5fbba9b213df","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/cbcc6532-409d-4dfe-9ca9-5fbba9b213df/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Matt McGinley","dt_posted":"2026-07-17T10:50:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2503-D Harrison Street North #1210","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22207","registrant":{"id":401103524,"url":"https://lda.gov/api/v1/registrants/401103524/","house_registrant_id":null,"name":"ADVANCED POLICY CONSULTING, LLC","description":"Consulting","address_1":"2503-D Harrison Street North #1210","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22207","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT MCGINLEY","contact_telephone":"+1 703-536-1705","dt_updated":"2026-07-24T11:29:57.639066-04:00"},"client":{"id":199385,"url":"https://lda.gov/api/v1/clients/199385/","client_id":176,"name":"HEALTH-E COMMERCE INCLUDING SUBSIDIARIES","general_description":"Healthcare e-commerce platform company.","client_government_entity":false,"client_self_select":null,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-03-05"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Protect the current FSA/HSA list of products and support expanding the list of allowable products for FSA/HSA. Monitor FSA/HSA legislation. Lobby for legislation that would expand the definition of prevention for FSA/HSA. Support vitamins and supplements as FSA/HSA eligible. Monitor FSA/HSA policy as it pertains to the ACA COVID subsides. H.R.8933 \"Dietary Supplements Access Act\" S. 4587, \"Dietary Supplements Access Act\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Protect the current FSA/HSA list of products and support expanding the list of allowable products for FSA/HSA. Monitor FSA/HSA legislation. Lobby for legislation that would expand the definition of prevention for FSA/HSA. Support vitamins and supplements as FSA/HSA eligible. Monitor FSA/HSA policy as it pertains to the ACA COVID subsides. H.R.8933 \"Dietary Supplements Access Act\" S. 4587, \"Dietary Supplements Access Act\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/cbcc6532-409d-4dfe-9ca9-5fbba9b213df/","filing_uuid":"cbcc6532-409d-4dfe-9ca9-5fbba9b213df","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/cbcc6532-409d-4dfe-9ca9-5fbba9b213df/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Matt McGinley","dt_posted":"2026-07-17T10:50:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2503-D Harrison Street North #1210","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22207","registrant":{"id":401103524,"url":"https://lda.gov/api/v1/registrants/401103524/","house_registrant_id":null,"name":"ADVANCED POLICY CONSULTING, LLC","description":"Consulting","address_1":"2503-D Harrison Street North #1210","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22207","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT MCGINLEY","contact_telephone":"+1 703-536-1705","dt_updated":"2026-07-24T11:29:57.639066-04:00"},"client":{"id":199385,"url":"https://lda.gov/api/v1/clients/199385/","client_id":176,"name":"HEALTH-E COMMERCE INCLUDING SUBSIDIARIES","general_description":"Healthcare e-commerce platform company.","client_government_entity":false,"client_self_select":null,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-03-05"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Protect the current FSA/HSA list of products and support expanding the list of allowable products for FSA/HSA. Monitor FSA/HSA legislation. Lobby for legislation that would expand the definition of prevention for FSA/HSA. Support vitamins and supplements as FSA/HSA eligible. Monitor FSA/HSA policy as it pertains to the ACA COVID subsides. H.R.8933 \"Dietary Supplements Access Act\" S. 4587, \"Dietary Supplements Access Act\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Protect the current FSA/HSA list of products and support expanding the list of allowable products for FSA/HSA. Monitor FSA/HSA legislation. Lobby for legislation that would expand the definition of prevention for FSA/HSA. Support vitamins and supplements as FSA/HSA eligible. Monitor FSA/HSA policy as it pertains to the ACA COVID subsides. H.R.8933 \"Dietary Supplements Access Act\" S. 4587, \"Dietary Supplements Access Act\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/cb8e042a-9eb5-4468-8c6e-f46e906a40ad/","filing_uuid":"cb8e042a-9eb5-4468-8c6e-f46e906a40ad","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/cb8e042a-9eb5-4468-8c6e-f46e906a40ad/print/","filing_document_content_type":"text/html","income":null,"expenses":"100000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julia Gustafson - Vice President, Government Relations","dt_posted":"2026-07-17T17:06:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1828 L STREET, NW","registrant_address_2":"SUITE 220","registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":11036,"url":"https://lda.gov/api/v1/registrants/11036/","house_registrant_id":32051,"name":"COUNCIL FOR RESPONSIBLE NUTRITION","description":null,"address_1":"1828 L STREET, NW","address_2":"SUITE 220","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIA GUSTAFSON","contact_telephone":"+1 202-204-7690","dt_updated":"2026-07-28T10:35:13.824263-04:00"},"client":{"id":114917,"url":"https://lda.gov/api/v1/clients/114917/","client_id":12,"name":"COUNCIL FOR RESPONSIBLE NUTRITION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to tariffs and impact on the dietary supplement industry.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Issues related to recycled materials policy and environmental attribution, including H.R.7502, The Recycled Materials Attribution Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":153601,"prefix":null,"prefix_display":null,"first_name":"MIKE","nickname":null,"middle_name":null,"last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Monitored any issues related to the dietary supplements industry, including H.R.8962, The PERFECT Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"All efforts related to the inclusion of dietary supplement purchases within tax-deductible Health Savings Accounts and Flexible Spending Accounts (HSAs/FSAs), including S. 4587 and H.R. 8933, the Dietary Supplements Access Act of 2026. Issues related to IRS guidance on the classification of dietary supplements as qualified medical expenses for HSAs and FSAs (IRS Publication 502).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory product listing requirements for dietary supplements, including S. 3677 and H.R. 8370, the Dietary Supplement Listing Act of 2026. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to the generally recognized as safe (GRAS) process. General issues related to the dietary supplement industry.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1cff5f52-6445-4fae-ac64-453a1cc151f9/","filing_uuid":"1cff5f52-6445-4fae-ac64-453a1cc151f9","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1cff5f52-6445-4fae-ac64-453a1cc151f9/print/","filing_document_content_type":"text/html","income":null,"expenses":"90000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Ingrid Lebert","dt_posted":"2026-08-07T11:38:12-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"8531 Fallbrook Ave.","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"West Hills","registrant_state":"CA","registrant_zip":"91304","registrant":{"id":286074,"url":"https://lda.gov/api/v1/registrants/286074/","house_registrant_id":36957,"name":"PHARMAVITE LLC","description":null,"address_1":"8531 Fallbrook Ave.","address_2":null,"address_3":null,"address_4":null,"city":"West Hills","state":"CA","state_display":"California","zip":"91304","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"INGRID LEBERT","contact_telephone":"+1 202-492-4486","dt_updated":"2026-10-09T08:48:27.189961-04:00"},"client":{"id":176428,"url":"https://lda.gov/api/v1/clients/176428/","client_id":12,"name":"PHARMAVITE LLC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-03"},"lobbying_activities":[{"general_issue_code":"FOO","general_issue_code_display":"Food Industry (safety, labeling, etc.)","description":"H.R.4306 - a bill to amend the Federal Food, Drug, and Cosmetic Act to require the Office of Food Chemical Safety, Dietary Supplements, and Innovation to conduct food chemical safety reassessments, and for other purposes; all provisions related to dietary supplements. H.R. 4968 - a bill to amend the Federal Food, Drug, and Cosmetic Act to require notification to the Food and Drug Administration prior to use of substances as generally recognized as safe, reassessment of the safety of certain substances marketed as generally recognized as safe, provide resources for reviews and reassessments, and for other purposes; all provisions related to dietary supplements S.2341 - A bill to amend the Federal Food, Drug, and Cosmetic Act to impose requirements for substances generally recognized as safe, to require the Commissioner of Food and Drugs to reassess the safety of chemicals added to food, and for other purposes; all provisions related to dietary supplements. H.R. 4958, Grocery Reform and Safety (GRAS) Act (Rep. Pallone), all provisions related to dietary supplements. H.R. 7291, GRAS Oversight and Transparency Act (Rep. Lawler), all provisions related to dietary supplements. H.R. ____, [FDA Review and Evaluation for Safe, Healthy and Affordable Foods Act of 2026] (Rep. Cammack), all provisions related to dietary supplements. H.R. 8370, Dietary Supplement Listing Act of 2026 (Rep. Dexter), all provisions related to dietary supplements. S. 3677, Dietary Supplement Listing Act of 2026 (Sen. Durbin), all provisions related to dietary supplements. H.R. 7366, Dietary Supplement Regulatory Uniformity Act (Rep. Langworthy), all provisions related to dietary supplements. H.R. 8385, Food Labeling Modernization Act of 2026 (Rep. Pallone), all provisions related to dietary supplements. S. 3797, a bill to amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements (Sen. Durbin), all provisions related to dietary supplements. H.R. 8933, a bill to amend the Internal Revenue Code of 1986 to include dietary supplements as qualified medical expenses (Rep. LaHood) S. 4587, a bill to amend the Internal Revenue Code of 1986 to include dietary supplements as qualified medical expenses (Sen. Cramer) H.R. 8962, a bill to amend title 10, United States Code, to direct the Secretary of Defense to publish a list of dietary supplement ingredients prohibited for use by members of the Armed Forces, and for other purposes (Rep. Davidson) S. 4626, a bill to amend title 10, United States Code, to direct the Secretary of Defense to publish a list of dietary supplement ingredients prohibited for use by members of the Armed Forces, and for other purposes (Sen. Lee)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71867,"prefix":null,"prefix_display":null,"first_name":"INGRID","nickname":null,"middle_name":null,"last_name":"LEBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients / 2025-06587 (90 FR 15951)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71867,"prefix":null,"prefix_display":null,"first_name":"INGRID","nickname":null,"middle_name":null,"last_name":"LEBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"S. 1071 - National Defense Authorization Act for Fiscal Year 2026 - a bill to authorize appropriations for fiscal year 2026 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; all provisions related to dietary supplements.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71867,"prefix":null,"prefix_display":null,"first_name":"INGRID","nickname":null,"middle_name":null,"last_name":"LEBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"H.R. ____, [Securing and Establishing Consumer Uniform Rights and Enforcement over Data Act / SECURE Data Act] (Rep. Joyce), all provisions related to dietary supplements.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":153873,"prefix":null,"prefix_display":null,"first_name":"INGRID","nickname":null,"middle_name":null,"last_name":"PHARMAVITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2d04443b-61d1-4e39-b391-6f2a16786297/","filing_uuid":"2d04443b-61d1-4e39-b391-6f2a16786297","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/2d04443b-61d1-4e39-b391-6f2a16786297/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Matt McGinley","dt_posted":"2026-10-13T10:19:17-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2503-D Harrison Street North #1210","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22207","registrant":{"id":401103524,"url":"https://lda.gov/api/v1/registrants/401103524/","house_registrant_id":null,"name":"ADVANCED POLICY CONSULTING, LLC","description":"Consulting","address_1":"2503-D Harrison Street North #1210","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22207","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT MCGINLEY","contact_telephone":"+1 703-536-1705","dt_updated":"2026-07-24T11:29:57.639066-04:00"},"client":{"id":199385,"url":"https://lda.gov/api/v1/clients/199385/","client_id":176,"name":"HEALTH-E COMMERCE INCLUDING SUBSIDIARIES","general_description":"Healthcare e-commerce platform company.","client_government_entity":false,"client_self_select":null,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-03-05"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Protect the current FSA/HSA list of products and support expanding the list of allowable products for FSA/HSA. Monitor FSA/HSA legislation. Lobby for legislation that would expand the definition of prevention for FSA/HSA. Support vitamins and supplements as FSA/HSA eligible. Monitor FSA/HSA policy as it pertains to the ACA COVID subsides. H.R.8933 \"Dietary Supplements Access Act\" S. 4587, \"Dietary Supplements Access Act\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Protect the current FSA/HSA list of products and support expanding the list of allowable products for FSA/HSA. Monitor FSA/HSA legislation. Lobby for legislation that would expand the definition of prevention for FSA/HSA. Support vitamins and supplements as FSA/HSA eligible. Monitor FSA/HSA policy as it pertains to the ACA COVID subsides. H.R.8933 \"Dietary Supplements Access Act\" S. 4587, \"Dietary Supplements Access Act\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2d04443b-61d1-4e39-b391-6f2a16786297/","filing_uuid":"2d04443b-61d1-4e39-b391-6f2a16786297","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/2d04443b-61d1-4e39-b391-6f2a16786297/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Matt McGinley","dt_posted":"2026-10-13T10:19:17-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2503-D Harrison Street North #1210","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22207","registrant":{"id":401103524,"url":"https://lda.gov/api/v1/registrants/401103524/","house_registrant_id":null,"name":"ADVANCED POLICY CONSULTING, LLC","description":"Consulting","address_1":"2503-D Harrison Street North #1210","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22207","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT MCGINLEY","contact_telephone":"+1 703-536-1705","dt_updated":"2026-07-24T11:29:57.639066-04:00"},"client":{"id":199385,"url":"https://lda.gov/api/v1/clients/199385/","client_id":176,"name":"HEALTH-E COMMERCE INCLUDING SUBSIDIARIES","general_description":"Healthcare e-commerce platform company.","client_government_entity":false,"client_self_select":null,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-03-05"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Protect the current FSA/HSA list of products and support expanding the list of allowable products for FSA/HSA. Monitor FSA/HSA legislation. Lobby for legislation that would expand the definition of prevention for FSA/HSA. Support vitamins and supplements as FSA/HSA eligible. Monitor FSA/HSA policy as it pertains to the ACA COVID subsides. H.R.8933 \"Dietary Supplements Access Act\" S. 4587, \"Dietary Supplements Access Act\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Protect the current FSA/HSA list of products and support expanding the list of allowable products for FSA/HSA. Monitor FSA/HSA legislation. Lobby for legislation that would expand the definition of prevention for FSA/HSA. Support vitamins and supplements as FSA/HSA eligible. Monitor FSA/HSA policy as it pertains to the ACA COVID subsides. H.R.8933 \"Dietary Supplements Access Act\" S. 4587, \"Dietary Supplements Access Act\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":188,"name":"Internal Revenue Service (IRS)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5365ef14-38a7-46f6-bb93-864fad8aaa27/","filing_uuid":"5365ef14-38a7-46f6-bb93-864fad8aaa27","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/5365ef14-38a7-46f6-bb93-864fad8aaa27/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julia Gustafson - Vice President, Government Relations","dt_posted":"2026-10-19T14:05:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1828 L STREET, NW","registrant_address_2":"SUITE 220","registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":11036,"url":"https://lda.gov/api/v1/registrants/11036/","house_registrant_id":32051,"name":"COUNCIL FOR RESPONSIBLE NUTRITION","description":null,"address_1":"1828 L STREET, NW","address_2":"SUITE 220","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIA GUSTAFSON","contact_telephone":"+1 202-204-7690","dt_updated":"2026-07-28T10:35:13.824263-04:00"},"client":{"id":114917,"url":"https://lda.gov/api/v1/clients/114917/","client_id":12,"name":"COUNCIL FOR RESPONSIBLE NUTRITION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"All efforts related to the inclusion of dietary supplement purchases within tax-deductible Health Savings Accounts and Flexible Spending Accounts (HSAs/FSAs), including S. 4587 and H.R. 8933, the Dietary Supplements Access Act of 2026. Issues related to IRS guidance on the classification of dietary supplements as qualified medical expenses for HSAs and FSAs (IRS Publication 502).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory product listing requirements for dietary supplements, including S. 3677 and H.R. 8370, the Dietary Supplement Listing Act of 2026. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision, including H.R. 10336, the Dietary Supplement Innovation Act of 2026. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to the generally recognized as safe (GRAS) process. Issues related to FDA's \"Simple Reform\" reorganization and its impact on dietary supplement facility inspections and specialized inspectional expertise. General issues related to the dietary supplement industry.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to tariffs and impact on the dietary supplement industry.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Issues related to recycled materials policy and environmental attribution, including H.R.7502, The Recycled Materials Attribution Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Monitored any issues related to the dietary supplements industry, including H.R.8962, The PERFECT Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143235,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"MISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72578,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":"L","last_name":"GUSTAFSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141115,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DAVID","last_name":"MEIROVITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3a15b988-939e-4b83-bd85-ebf515e710a7/","filing_uuid":"3a15b988-939e-4b83-bd85-ebf515e710a7","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/3a15b988-939e-4b83-bd85-ebf515e710a7/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Isabella Quinn","dt_posted":"2026-10-20T12:09:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 Pennsylvania Avenue, NW","registrant_address_2":"Suite 800","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":41454,"url":"https://lda.gov/api/v1/registrants/41454/","house_registrant_id":30771,"name":"WILLIAMS AND JENSEN, PLLC","description":"Lobbying Law Firm","address_1":"1201 Pennsylvania Avenue, NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ISABELLA QUINN","contact_telephone":"+1 202-659-8201","dt_updated":"2026-07-30T10:41:36.640087-04:00"},"client":{"id":66888,"url":"https://lda.gov/api/v1/clients/66888/","client_id":66888,"name":"THE COUNCIL FOR RESPONSIBLE NUTRITION","general_description":"Dietary supplement trade association","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-05-15"},"lobbying_activities":[{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Monitored the NDAA for any issues related to the dietary supplements industry.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Monitoring issues related to tariffs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory Product Listing for dietary supplements. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision. General issues related to the dietary supplement industry. H.R. 7366 (Dietary Supplement Regulatory Uniformity Act).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"All legislative proposals related to the inclusion of dietary supplement purchases within tax-deductible Health Savings Accounts and Flexible Spending Accounts (HSAs/FSAs) H.R. 8933 and S. 4587 (Dietary Supplements Access Act).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false},{"lobbyist":{"id":43332,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"W","last_name":"HATCHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/8e6ba24f-43cf-4fc2-96b0-406e9f7a0286/","filing_uuid":"8e6ba24f-43cf-4fc2-96b0-406e9f7a0286","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/8e6ba24f-43cf-4fc2-96b0-406e9f7a0286/print/","filing_document_content_type":"text/html","income":null,"expenses":"1710000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Michael Parrish","dt_posted":"2026-10-20T16:14:24-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"801 Pennsylvania Ave., NW Suite 900","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":5632,"url":"https://lda.gov/api/v1/registrants/5632/","house_registrant_id":31257,"name":"BAYER CORPORATION (CONSOLIDATED REPORT)","description":null,"address_1":"801 Pennsylvania Ave., NW Suite 900","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL PARRISH","contact_telephone":"+1 202-737-8900","dt_updated":"2026-07-30T15:08:38.983388-04:00"},"client":{"id":107401,"url":"https://lda.gov/api/v1/clients/107401/","client_id":12,"name":"BAYER CORPORATION (CONSOLIDATED REPORT)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Monitor and engage on legislative and administrative action related to antitrust and competition.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"Monitor and engage on legislative and administrative action related to Federal Insecticide, Fungicide, Rodenticide (FIFRA) Regulations. Monitor and engage on legislative and administrative action related to the Endangered Species Act and related reforms. Monitor and engage on legislative and administrative action related to 7 CFR Part 340. Monitor and engage on legislative and administrative action related to biotech innovation and regulation. Monitor and engage on legislative and administrative action related to international adoption of DNA marker evidence for plant variety protection patent. Monitor and engage on legislative and administrative action related to the programs of the Natural Resources Conservation Service (NRCS). Monitor and engage on legislative and administrative action related to food security and nutrition. Monitor and engage on legislative and administrative action related to biofuels, including ethanol, the RFS, and sustainable aviation fuel. Monitor and engage on legislative and administrative action related to Pesticides: Exemptions of Certain Plant-Incorporated Protectants Derived from Newer Technologies (Final Rule). Monitor and engage on legislative and administrative action related to reauthorization of Foundation for Food and Agriculture Research (FFAR). Monitor and engage on legislative and administrative action related to the Farm Bill reauthorization. Monitor and engage on legislative and administrative action related to Ag chemistry. Monitor and engage on legislative and administrative action related to the uniformity of pesticide labeling. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on the implementation of One Big Beautiful Bill Act (Pub. Law. 119-21). H.R. 7567, Farm, Food and National Security Act of 2026, including Section 10205 -- Uniformity of Pesticide Labeling Requirements. H.R. 7601, No Immunity for Glyphosate Act. H.R. 9528, People Over Poison Act. H.R. 9681, Fair Seeds for Farmers Act. H.R. 9807, Americans vs. Poisonous Pesticides Act. S. 4425, No Immunity for Glyphosate Act. S. 5104, Fair Seeds for Farmers Act. S. 5526, Agricultural Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71414,"prefix":null,"prefix_display":null,"first_name":"JIM","nickname":null,"middle_name":null,"last_name":"TRAVIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":15,"name":"Council on Environmental Quality (CEQ)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"},{"id":142,"name":"U.S. Fish & Wildlife Service (USFWS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Monitor and engage on legislative and administrative action on appropriations and budget. Monitor and engage on legislative and administrative action related to the uniformity of pesticide labeling. Monitor and engage on legislative and administrative action related to FY2027 Interior, Environment, and Related Agencies Appropriations Acts. Monitor and engage on legislative and administrative action related to FY2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Acts. H.R. 9171, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2027. H.R. 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62033,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"NAGLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71414,"prefix":null,"prefix_display":null,"first_name":"JIM","nickname":null,"middle_name":null,"last_name":"TRAVIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154612,"prefix":null,"prefix_display":null,"first_name":"ERICA","nickname":null,"middle_name":null,"last_name":"CISCHKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Monitor and engage on legislative and administrative action related to intellectual property protection. Monitor and engage on legislative and administrative action related to 35 USC 101 reform. H.R. 1574, RESTORE Patent Rights Act of 2025. H.R. 3152, Patent Eligibility Restoration Act of 2025. H.R. 3160, PREVAIL Act. H.R. 3269, ETHIC Act. H.R. 9681, Fair Seeds for Farmers Act. S. 708, RESTORE Patent Rights Act of 2025. S. 1546, Patent Eligibility Restoration Act of 2025. S. 1553, PREVAIL Act. S. 2276, ETHIC Act. S. 5104, Fair Seeds for Farmers Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62033,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"NAGLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitor and engage on legislative and administrative action related to health care policy. Monitor and engage on legislative and administrative action related to womens health issues. Monitor and engage on legislative and administrative action related to regulation of over-the-counter medicines. Monitor and engage on legislative and administrative action related to dietary supplements, including FDA regulation of ingredients. Monitor and engage on legislative and administrative action related to servicing of medical device equipment. Monitor and engage on legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor and engage on legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor and engage on legislative and administrative action related to 340B drug discount program. Monitor and engage on legislative and administrative action related to drug supply chain issues, including pharmacy benefit manager (PBM) reform. Monitor and engage on legislative and administrative action related to copay assistance. Monitor and engage on legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor and engage on legislative and administrative action related to access to treatments for kidney disease patients. Monitor and engage on legislative and administrative action related to Make America Healthy Again (MAHA). Monitor and engage on legislative and administrative action related to generally recognized as safe (GRAS) rules for food additives. Monitor and engage on legislative and administrative action related to FDA regulation of cell and gene therapies. Monitor and engage on legislative and administrative action related to Parkinsons disease. Monitor and engage on legislative and administrative action related to federal investment in biotech development and manufacturing. H.R. 5509, Safe Step Act. H.R. 6118, Support and Defend Our Military Personnel and Their Families Act. H.R. 7366, Dietary Supplement Regulatory Uniformity Act. H.R. 8933, Dietary Supplements Access Act. H.R. 9090, Advancing Menopause Care and Mid-Life Womens Health Act. S. 2903, Safe Step Act. S. 3122, Better Food Disclosure Act of 2025. S. 3677, Dietary Supplement Listing Act of 2026. S. 3788, CLEAR Labels Act. S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act. S. 4587, Dietary Supplements Access Act. S. 5260, Stroke Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62033,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"NAGLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154612,"prefix":null,"prefix_display":null,"first_name":"ERICA","nickname":null,"middle_name":null,"last_name":"CISCHKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Monitor and engage on legislative and administrative action related to Medicare and Medicaid policy. Monitor the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169). Monitor and engage on legislative and administrative action related to Medicare inpatient reimbursement for cell and gene therapies. H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 7871, Medicaid VBPs for Patients Act (MVP Act). S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act of 2025.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62033,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"NAGLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154612,"prefix":null,"prefix_display":null,"first_name":"ERICA","nickname":null,"middle_name":null,"last_name":"CISCHKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Monitor and engage on legislative and administrative action related to Section 301 tariffs. Monitor and engage on legislative and administrative action related to tariff deferment. Monitor and engage on legislative and administrative action related to tariff suspensions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71414,"prefix":null,"prefix_display":null,"first_name":"JIM","nickname":null,"middle_name":null,"last_name":"TRAVIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Monitor and engage on legislative and federal activity related to tax reform. Monitor and engage on legislative and administrative action related to implementation of P.L. 115-97, Tax Cuts and Jobs Act. Monitor and engage on legislative and administrative action related to including dietary supplements as reimbursable expenses in tax-preferred savings accounts. Monitor and engage on legislative and administrative issues related to foreign tax credit regulations. Monitor and engage on the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169), including the section 45Z tax credit and the sustainable aviation fuel tax credit. Monitor and engage on the implementation of One Big Beautiful Bill Act (Pub. Law. 119-21).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62033,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"NAGLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154612,"prefix":null,"prefix_display":null,"first_name":"ERICA","nickname":null,"middle_name":null,"last_name":"CISCHKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Monitor and engage on legislative and administrative action related to trade. Monitor and engage on legislative and administrative action related to foreign regulation of chemicals, pesticides, pharmaceuticals, and health care products. Monitor and engage on legislative and administrative action related to China import approvals, and foreign direct investment prohibitions and restrictions. Monitor and engage in administrative action related to maximum residue levels (MRLs) in the ASEAN region. Monitor and engage on legislative and administrative action related to foreign agriculture laws, regulations, and trade. Monitor and engage on legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor and engage on legislative and administrative action related to Korea import approvals. Monitor and engage on legislative and administrative action related to intellectual property issues and regulations in India. Monitor and engage on legislative and administrative action related to World Trade Organization (WTO) digital trade rules. Monitor and engage on legislative and administrative action related to Section 301 tariffs. Monitor and engage on legislative and administrative action related to Section 232 tariffs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71414,"prefix":null,"prefix_display":null,"first_name":"JIM","nickname":null,"middle_name":null,"last_name":"TRAVIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":198,"name":"Natl Economic Council (NEC)"},{"id":16,"name":"Natl Security Council (NSC)"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":41,"name":"Treasury, Dept of"},{"id":196,"name":"U.S. Agency for International Development (USAID)"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"ENG","general_issue_code_display":"Energy/Nuclear","description":"Monitor and engage on legislative and administrative action related to Biofuels and the Renewable Fuel Standard. Monitor and engage on the implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58). Monitor and engage on the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"NAT","general_issue_code_display":"Natural Resources","description":"Monitor and engage on legislative and administrative action related to phosphate mining operations and permits. Monitor and engage on legislative and administrative action related to the Endangered Species Act. Monitor and engage on legislative and administrative action related to the Fairness and Certainty in Reclamation Act (no bill number yet). H.R. 1897, ESA Amendments Act of 2025.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":148,"name":"Bureau of Land Management (BLM)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":36,"name":"Interior, Dept of (DOI)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":144,"name":"U.S. Geological Survey (USGS)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Monitor and engage on legislative and administrative action related to climate change, including sustainable agriculture. Monitor and engage on legislative and administrative action related to FIFRA Regulations, including voluntary carbon markets. Monitor and engage on legislative and administrative action related to the Endangered Species Act. H.R. 1897, ESA Amendments Act of 2025.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70509,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HOLLAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70512,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"PARRISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70513,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"MURPHY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142398,"prefix":null,"prefix_display":null,"first_name":"ERICK","nickname":null,"middle_name":null,"last_name":"LUTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":23,"name":"Agriculture, Dept of (USDA)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":142,"name":"U.S. Fish & Wildlife Service (USFWS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}